Abstract
Polypoidal Choroidal Vasculopathy (PCV) is a condition characterized by chronic, multiple, recurrent serous and/or hemorrhagic detachments of the retinal pigment epithelium (RPE) and neurosensory retina. Although it has been described to more often affect Asians and individuals of pigmented races, PCV may also be present in white patients who present with the clinical appearance of age related macular degeneration (AMD). PCV and its treatment are discussed, including the use of combination therapy.
Keywords: Polypoidal choroidal vasculopathy, choroidal neovascularization, age-related macular degeneration, photodynamic therapy, antiVEGF, triamcinolone, combination therapy, retinal pigment epithelium (RPE), neurosensory retina, serosanguinous retinal pigment epithelial (RPE), macula, extrafovea, subfovea, juxtafovea, Optical Coherence Tomography, fundus, Fluorescein Angiography, Indocyanine Green Angiography, hemorrhage, vascular dilations, transpupillary thermotherapy (TTT), Laser Photocoagulation, polypoidal lesion, photothrombosis, Intravitreal Anti-VEGF Therapy, Intravitreal Triamcinolone Acetonide
Current Drug Targets
Title: Polypoidal Choroidal Vasculopathy: Recent Advances in Therapy
Volume: 12 Issue: 2
Author(s): G. de Crecchio, R. V.P. Chan, G. Manzi and M. R. Romano
Affiliation:
Keywords: Polypoidal choroidal vasculopathy, choroidal neovascularization, age-related macular degeneration, photodynamic therapy, antiVEGF, triamcinolone, combination therapy, retinal pigment epithelium (RPE), neurosensory retina, serosanguinous retinal pigment epithelial (RPE), macula, extrafovea, subfovea, juxtafovea, Optical Coherence Tomography, fundus, Fluorescein Angiography, Indocyanine Green Angiography, hemorrhage, vascular dilations, transpupillary thermotherapy (TTT), Laser Photocoagulation, polypoidal lesion, photothrombosis, Intravitreal Anti-VEGF Therapy, Intravitreal Triamcinolone Acetonide
Abstract: Polypoidal Choroidal Vasculopathy (PCV) is a condition characterized by chronic, multiple, recurrent serous and/or hemorrhagic detachments of the retinal pigment epithelium (RPE) and neurosensory retina. Although it has been described to more often affect Asians and individuals of pigmented races, PCV may also be present in white patients who present with the clinical appearance of age related macular degeneration (AMD). PCV and its treatment are discussed, including the use of combination therapy.
Export Options
About this article
Cite this article as:
de Crecchio G., V.P. Chan R., Manzi G. and R. Romano M., Polypoidal Choroidal Vasculopathy: Recent Advances in Therapy, Current Drug Targets 2011; 12(2) . https://dx.doi.org/10.2174/138945011794182782
DOI https://dx.doi.org/10.2174/138945011794182782 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide for New Editors
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
OPA1 in Cardiovascular Health and Disease
Current Drug Targets Hypotensive Natural Products: Current Status
Mini-Reviews in Medicinal Chemistry Complex of Nifedipine with Glycyrrhizic Acid as a Novel Water-Soluble Antihypertensive and Antiarrhythmic Agent
Letters in Drug Design & Discovery Analogy of Cardiac and Renal Complications in Essential Hypertension and Aged SHR or L-NAME/SHR
Medicinal Chemistry The Evaluation of Valsartan Biopharmaceutics Properties
Current Drug Research Reviews Anti-Angiogenic Agents in Pancreatic Cancer: A Review
Anti-Cancer Agents in Medicinal Chemistry Phytochemical Therapies in Vascular Functioning: A Molecular Approach
Current Vascular Pharmacology The Physiology and Pathophysiology of a Novel Angiotensin Receptor-binding Protein ATRAP/Agtrap
Current Pharmaceutical Design Diagnostic Tools, Biomarkers, and Treatments in Diabetic polyneuropathy and Cardiovascular Autonomic Neuropathy
Current Diabetes Reviews The Role of Endothelin System in Cardiovascular Disease and the Potential Therapeutic Perspectives of its Inhibition
Current Topics in Medicinal Chemistry Decreasing Arterial Aging by Controlling Blood Pressure Levels and Hypertension: A Step Forward
Current Vascular Pharmacology Normal and Pathological Erectile Function The Potential Clinical Role of Endothelin-1 Antagonists
Current Drug Targets Role of PI3K/AKT, cPLA2 and ERK1/2 Signaling Pathways in Insulin Regulation of Vascular Smooth Muscle Cells Proliferation
Cardiovascular & Hematological Disorders-Drug Targets Properties and Distribution of Angiotensin I Converting Enzyme
Current Pharmaceutical Design Systemic Adverse Drug Reactions Secondary to Anti-VEGF Intravitreal Injection in Patients with Neovascular Age-Related Macular Degeneration
Current Vascular Pharmacology Novel Insights into Vascular Repair Mechanisms
Current Pharmaceutical Design Cellular Actions of Nesfatin-1 on Hypothalamic and Medullary Neurons
Current Pharmaceutical Design Aspartic Proteinases in Disease: A Structural Perspective
Current Drug Targets Therapeutic Targets to Raise HDL in Patients at Risk or with Coronary Artery Disease
Current Vascular Pharmacology Systematic Review and Meta-analysis of Pharmacological Interventions for Weight Gain from Antipsychotics and Mood Stabilizers
Current Psychiatry Reviews